flosz schreef:
[quote=patrick1968]
Partnering & Outsourcing Models in Biology & Pre-clinical R&D
20-21 February, 2007 in San Diego (USA)
Onno van de Stolpe, CEO, presenting
[/quote]
Day One
Tuesday, February 20, 2007
8:35 Case Study of a Turn-key Alliance Between GSK and Galapagos: From Target to Phase II in Osteoarthritis
In June, GSK's CEEDD and Galapagos signed a multi year alliance in osteoarthritis in which Galapagos takes up the responsibility in discovering novel disease targets, identifying small molecules and bringing candidate drugs into the clinic through to phase IIa. We'll discuss the rationale and structure of this outsourcing partnership, and show how this innovative risk/reward sharing model can be the basis for many more alliances between big pharma and biotech.
Onno van de Stolpe, CEO, Galapagos NV, Belgium
Damien McDevitt, Ph.D., Director, Transactions and Ventures, Worldwide Business Development, GlaxoSmithKline
Panel Discussion
11:35 Comparative Strategies for Building an R&D Pipeline
Outsourcing components of your R&D effort
Build your own facility/capability
Collaborative partnerships and risk-sharing
Innovative models for collaboration
Moderator: Daniel R. Passeri, President and CEO, Curis, Inc. Panelists:
Jitendra Patel, Ph.D., Director, Strategic Planning and Business Development - CNS, AstraZeneca Pharmaceuticals
Damien McDevitt, Ph.D., Director, Transactions and Ventures, Worldwide Business Development, GlaxoSmithKline
Onno van de Stolpe, CEO, Galapagos NV, Belgium
Blake Salisbury, Senior Manager, Discovery/Technology, Corporate Business Development, Eli Lilly & Co.
Charles Hedgecock, Ph.D., Principal Scientist, Discovery Research, Biovitrum AB, Sweden
Day Two
February 21, 2007
11:40
Screening on Disease-related Primary Cell Systems for Target Finding and Hit Finding
PrimePath is a new service from BioFocus DPI that allows outsourcing of screening using disease-related human primary cells. The talk will explore examples of primary cell models, review the use of primary cells for target finding and highlight the recent trend for using primary cells to screen compound libraries.
Iain James, Ph.D., Senior Director, Biology, Biofocus DPI
www.ibclifesciences.com/D3214/2171.xml